Less Ads, More Data, More Tools Register for FREE

Pin to quick picksProteome Regulatory News (PRM)

Share Price Information for Proteome (PRM)

Share Price is delayed by 15 minutes
Get Live Data
1.61    0.205 (12.81%)
Bid:
1.61
Ask:
2.00
Spread: 0.39 (24.224%)
Market Cap: £5.65m
PRM Live PriceLast checked at - London Stock Exchange

Intraday Proteome Share Chart

Holding(s) in Company

1 Apr 2008 15:20

TR-1: NOTIFICATION OF MAJOR INTERESTS IN SHARES 1. Identity of the issuer or the underlying Proteome Securities Plc issuer of existing shares to which voting

rights are attached:

2. Reason for the notification (please tick the appropriate box or

boxes) An acquisition or disposal of voting rights

Yes

An acquisition or disposal of financial instruments which may result in the acquisition of shares already issued to which voting rights are

attached

An event changing the breakdown of voting rights 3. Full name of person(s) subject to the Cubana Investments Limited

notification obligation:

4. Full name of shareholder(s) (if different

from 3.):

5. Date of the transaction (and date on which 01 April 2008 the threshold is crossed or reached if

different):

6. Date on which issuer notified: 01 April 2008 7. Threshold(s) that is/are crossed or reached: >8%

8. Notified details:

A: Voting rights attached to shares

Class/type Situation previous Resulting situation after the triggering of shares to the Triggering transaction transaction if possible using the ISIN CODE Number of Number of Number of Number of voting % of voting Shares Voting shares rights rights Rights Direct Indirect Direct Indirect

GB0003104196 10,374,272 10,374,272 10,531,272 10,531,272 10,531,272

8.01% B: Financial Instruments

Resulting situation after the triggering transaction

Type of Expiration Exercise/ Number of voting % of voting financial date Conversion Period/ rights that may be rights instrument Date acquired if the instrument is exercised/ converted N/A N/A N/A N/A N/A Total (A+B) Number of voting rights % of voting rights 10,531,272 8.01

9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable:

N/A Proxy Voting: 10. Name of the proxy holder: N/A

11. Number of voting rights proxy holder will N/A

cease to hold:

12. Date on which proxy holder will cease to hold N/A

voting rights: 13. Additional Information Contact name: James Malthouse Contact Telephone number: +44 1932 865065

Note: Annex should only be submitted to the FSA not the issuer

Annex: Notification Of Major Interests In Shares

A: Identity of the person or legal entity subject to the notification

obligation

Full name (including legal form for legal Cubana Investments Limited

entities) Contact address (registered office for PO Box 957, Offshore Incorporationslegal entities) Centre, Road Town, Tortola, British Virgin Islands

Other useful information (at least legal representative for legal persons) B: Identity of the notifier, if applicable

Full name Mirza Rahman Contact address 2 Battery Road, #26-01 Maybank Tower, Singapore 049907 Phone number +65 65381998 : msrahman@artradis.com

Other useful information (e.g. functional Compliance Officer relationship with the person or legal entity subject to the notification

obligation) C: Additional information

PROTEOME SCIENCES PLC
Date   Source Headline
12th Nov 20147:00 amRNSTrading Update
16th Oct 20147:00 amRNSDirectorate Change
1st Oct 20143:54 pmRNSDirector/PDMR Shareholding
30th Sep 20147:01 amRNSBlocklisting Interim Review
30th Sep 20147:00 amRNSDirectorate Change
30th Sep 20147:00 amRNSHalf Yearly Report
26th Sep 20147:00 amRNSCK1d Update: Toxicity Results
25th Sep 201410:08 amRNSContract with Genting TauRx Diagnostic Centre
15th Sep 20147:00 amRNSScience and Technology Award
19th Aug 20147:00 amRNSAppointment of Joint Broker
8th Jul 20145:45 pmRNSDirector/PDMR Shareholding
8th Jul 20147:00 amRNSAlzheimer's blood test study
1st Jul 20147:00 amRNSDirectorate Change
30th Jun 20144:42 pmRNSResult of AGM
9th Jun 20144:18 pmRNSAnnual Financial Report
29th May 20147:00 amRNSPreliminary results
1st Apr 20147:00 amRNSBlocklisting Interim Review
27th Mar 20147:00 amRNSPancreatic Cancer Study in PLOS ONE
3rd Mar 20144:25 pmRNSDirectorate Change
28th Feb 20143:46 pmRNSHolding(s) in Company
24th Feb 20147:00 amRNSPlacing
7th Feb 20147:00 amRNSTrading Update
3rd Feb 20144:44 pmRNSHolding(s) in Company
27th Dec 20134:35 pmRNSPrice Monitoring Extension
4th Dec 20137:00 amRNSTrading Update
20th Nov 20137:00 amRNSPatient Stratification Biomarkers for Liver Cancer
6th Nov 20132:51 pmRNSHolding(s) in Company
1st Oct 201310:34 amRNSBlocklisting Interim Review
30th Sep 20137:00 amRNSHalf Yearly Report
18th Sep 20132:00 pmRNSKey Assay Development at HUPO
2nd Sep 201312:12 pmRNSHolding(s) in Company
6th Aug 201312:36 pmRNSIssue of Equity
18th Jul 20137:00 amRNSNew Data Shows CK1d Blocks Tau in AD Model
28th Jun 20131:00 pmRNSAGM Statement
28th Jun 20137:00 amRNSPatent Statement
26th Jun 20139:27 amRNSHolding(s) in Company
12th Jun 20137:00 amRNSMajor technology contract
5th Jun 20134:08 pmRNSAnnual Financial Report
30th May 20137:01 amRNSPreliminary Results
19th Apr 20137:00 amRNSTrading Update
2nd Apr 20137:00 amRNSBlock admission return
18th Mar 20137:00 amRNSDevelopments in Alzheimer's Disease
22nd Jan 20137:00 amRNSTrading Statement
31st Dec 20127:00 amRNSCK1D Update
3rd Dec 201211:06 amRNSHolding(s) in Company
28th Sep 20127:00 amRNSHalf Yearly Report
18th Sep 20124:04 pmRNSBlock Admission Return
18th Sep 20124:01 pmRNSBlock Admission Return
18th Sep 20127:00 amRNSFurther re. University of Geneva Study
20th Aug 20127:00 amRNSRe Agreement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.